Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy

ClinicalTrials.gov ID: NCT02012218

Public ClinicalTrials.gov record NCT02012218. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multicenter, Open-label Exploratory Trial to Evaluate the Efficacy, Safety, and Subject Satisfaction With Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy

Study identification

NCT ID
NCT02012218
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
61 participants

Conditions and interventions

Interventions

  • ADT Drug
  • Brexpiprazole Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2013
Primary completion
Sep 30, 2014
Completion
Sep 30, 2014
Last update posted
Dec 28, 2015

2013 – 2014

United States locations

U.S. sites
24
U.S. states
20
U.S. cities
24
Facility City State ZIP Site status
Collaborative NeuroScience Network, Inc. Garden Grove California 92845
Viking Clinical Research, Ltd. Temecula California 92591
Clinical Neuroscience Solutions Pharmacology Orlando Florida 32806
Carman Research Smyrna Georgia 30080
Goldpoint Clinical Research Indianapolis Indiana 46260
Alpine Clinic Lafayette Indiana 47905
Pharmasite Research Baltimore Maryland 21208
Boston Clinical Trials Boston Massachusetts 02131
Coastal Research Associates, Inc. Weymouth Massachusetts 02190
Rochester Center for Behavioral Medicine Rochester Hills Michigan 48307
St. Louis Clinical Trials St Louis Missouri 63118
Center for Emotional Fitness Cherry Hill New Jersey 08002
Behavioral Medical Research of Staten Island Staten Island New York 10305
Richard H. Weisler, MD, PA Raleigh North Carolina 27609
Midwest Clinical Research Center MCRC Dayton Ohio 45417-3445
Cutting Edge Research Group Oklahoma City Oklahoma 73116
Oregon Center for Clinical Investigations, Inc. Portland Oregon 97210
Oregon Center for Clinical Investigations, Inc. Salem Oregon 97301
Lehigh Center for Clinical Research Allentown Pennsylvania 18104
Lincoln Research, LLC Lincoln Rhode Island 02865
Research Strategies of Memphis, LLC Memphis Tennessee 38119
Future Search Trials of Dallas, LP Dallas Texas 75231
NeuropsychiatricAssociates Woodstock Vermont 05091
Frontier Institute Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02012218, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 28, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02012218 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →